Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Cutaneous T-cell lymphoma-associated antigen HD-CL-03) (CTCL-associated antigen HD-CL-03) (Dehydrogenase/reductase SDR family member 8) (Retinal short-chain dehydrogenase/reductase 2) (retSDR2) (Short chain dehydrogenase/reductase family 16C member 2)
1_MKFLL 6_ DILLL 11_ LPLLI 16_ VCSLE 21_ SFVKL 26_ FIPKR 31_ RKSVT 36_ GEIVL 41_ ITGAG 46_ HGIGR 51_ LTAYE 56_ FAKLK 61_ SKLVL 66_ WDINK 71_ HGLEE 76_ TAAKC 81_ KGLGA 86_ KVHTF 91_ VVDCS 96_ NREDI 101_ YSSAK 106_ KVKAE 111_ IGDVS 116_ ILVNN 121_ AGVVY 126_ TSDLF 131_ ATQDP 136_ QIEKT 141_ FEVNV 146_ LAHFW 151_ TTKAF 156_ LPAMT 161_ KNNHG 166_ HIVTV 171_ ASAAG 176_ HVSVP 181_ FLLAY 186_ CSSKF 191_ AAVGF 196_ HKTLT 201_ DELAA 206_ LQITG 211_ VKTTC 216_ LCPNF 221_ VNTGF 226_ IKNPS 231_ TSLGP 236_ TLEPE 241_ EVVNR 246_ LMHGI 251_ LTEQK 256_ MIFIP 261_ SSIAF 266_ LTTLE 271_ RILPE 276_ RFLAV 281_ LKQKI 286_ SVKFD 291_AVIGY
1: Can convert androstan-3-alpha,17-beta-diol (3-alpha-diol) to androsterone in vitro, suggesting that it may participate in androgen metabolism during steroidogenesis. May act by metabolizing compounds that stimulate steroid synthesis and/or by generating metabolites that inhibit it. Has no activity toward DHEA (dehydroepiandrosterone), or A-dione (4-androste-3,17-dione), and only a slight activity toward testosterone to A-dione. Tumor-associated antigen in cutaneous T-cell lymphoma